您当前所在位置:首页 > 生命科学 > 新品上市
序号 标题 次数 作者 发布时间
90316 3,6-二氨基-1,2,4,5-四嗪-1,4-二氧化物 195 WYQ 2024-12-03
90317 1,6-二氢-1,2,4,5-四嗪化合物(1,6-Dihydro-1,2,4,5-Tetrazines) 265 WYQ 2024-12-03
90318 TCO-CC49 ,TCO功能化CC49抗体 250 wyh 2024-12-03
90319 [111In]In-DOTA-PEG11-BisPy-Tz 202 WYQ 2024-12-03
90320 3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) 160 WYQ 2024-12-03
90321 3,6-二烷基-1,2,4,5-四嗪(或-s-四嗪);3,6-dialkyl-1,2,4,5-tetrazines (or -s-tetrazines) 166 WYQ 2024-12-03
90322 3,6-双(2-吡啶基)-1,2,4,5-四嗪(bptz);3,6-bis(2-pyridyl)-1,2,4,5-tetrazine 212 WYQ 2024-12-03
90323 (DOTA)5-decalysine , (DOTA)5-十氢赖氨酸 148 wyh 2024-12-03
90324 3,6-dihydrazino-1,2,4,5-tetrazine(DHT) 178 WYQ 2024-12-03
90325 5-TAMRA-Tz;S-四嗪近红外花菁染料;5-TAMRA-tetrazine 194 WYQ 2024-12-03
90326 [64Cu]Cu-SarAr-Tz;(64)Cu标记四嗪放射性配体 334 WYQ 2024-12-03
90327 DOTA-monoamide,DOTA-单酰胺复合物 149 wyh 2024-12-03
90328 DOTA-PEG-RGD, DOTA-聚乙二醇-多肽 244 wyh 2024-12-03
90329 DOTA-PEGn-Cys-VS ,单分散PEG偶联螯合剂DO 181 wyh 2024-12-03
90330 甲氧基DOTA ,MeO-DOTA 360 wyh 2024-12-03
90331 DOTA-BASS , DOTA偶联sst拮抗剂 352 wyh 2024-12-03
90332 DOTA-phenylalanine,DOTA-苯丙氨酸 177 wyh 2024-12-03
90333 DOTA−Lysine−Biotin, DOTA -赖氨酸-生物素 173 wyh 2024-12-03
90334 DOTA-GA,螯合剂DOTA肽缀合物 188 wyh 2024-12-03
90335 DOTA共轭二膦酸盐,DOTA-HBP 183 wyh 2024-12-03
90336 DOTA-神经介素n ,DOTA-Neuromedin N 175 wyh 2024-12-03
90337 tris-烯丙基-DOTA , tris-allyl-DOTA 171 wyh 2024-12-03
90338 6-(苄氧羰基)氨基-3-(甲硫基)-1,2,4-四嗪;6-(benzyloxycarbonyl)amino-3-(methylthio)-1,2,4,5-tetrazine 169 WYQ 2024-12-03
90339 6-(乙酰氨基)-3-(甲硫基)-1,2,4-四嗪;6-(acetylamino)-3-(methylthio)-1,2,4,5-tetrazine 193 WYQ 2024-12-03
90340 cFLFLFK-PEG-DOTA ;细胞特异性肽-聚乙二醇-DOTA 154 wyh 2024-12-03
90341 6-[(叔丁氧基羰基)氨基]-3-(甲硫基)-1,2,4-四嗪;6-[(tert-butyloxycarbonyl)amino]-3-(methylthio)-1,2,4,5-tetrazine 173 WYQ 2024-12-03
90342 MMA-DOTA-Cys 61 ,DOTA-马来酰亚胺-半胱氨酸 218 wyh 2024-12-03
90343 DOTA-BR96 ,DOTA标记BR96单克隆抗体 189 wyh 2024-12-03
90344 DOTA-ggNle-cycmsh(hex),内酰胺桥环化肽偶联DOTA 178 wyh 2024-12-03
90345 DOTA-sCCK8[Phe2(p-CH2SO3H) ,大环DOTA偶联多肽 182 wyh 2024-12-03
90346 3,6-双(1H-1,2,3,4-四唑-5-基氨基)-1,2,4,5-四嗪(BTATz);3,6-bis(1H-1,2,3,4-tetrazol-5-yl-amino)- 1,2,4,5-tetrazine 172 WYQ 2024-12-03
90347 3,3'-偶氮二(6-氨基-1,2,4,5-四嗪)(DAAT);3,3'-azobis(6-amino-1,2,4,5-tetrazine) 362 WYQ 2024-12-03
90348 c(DOTA-RGDf),大环螯合剂DOTA环化RGD肽序列 209 wyh 2024-12-03
90349 3,6-双(吡啶-3-基)-1,2,4,5-四嗪(3,3'-吡喃);3,6-bis(pyridin-3-yl)-1,2,4,5-tetrazine (3,3'-pytz) 192 WYQ 2024-12-03
90350 3,6-双(2-甲氧基苯基)-1,2-二氢-1,2,4,5-四嗪(2-MDHT);3,6-bis(2-methoxyphenyl)-1,2-dihydro-1,2,4,5-tetrazine 193 WYQ 2024-12-03
90351 3,6-二甲基-1,2,4,5-四嗪;3,6-Dimethyl-1,2,4,5-tetrazine 207 WYQ 2024-12-03
90352 3,3'-偶氮(6-氨基-1,2,4,5-四嗪);3,3'-Azobis(6-amino-1,2,4,5-tetrazine)(DAAT) 228 WYQ 2024-12-03
90353 3,6-d二肼基-1,2,4,5-四嗪(DHT) 177 WYQ 2024-12-03
90354 DOTA-D-phe1-Tyr3-奥曲肽 ,Ga-68-DOTA-TATE 166 wyh 2024-12-03
90355 DOTA-cCCK,DOTA偶联胆囊收缩素(CCK)受体 304 wyh 2024-12-03
90356 3,6-d氨基-1,2,4,5-四嗪(DATZ) 203 WYQ 2024-12-03
90357 3-d氨基-6-(3,5-二甲基乙基吡唑-1-基)-1,2,4,5-四嗪(ADMPT) 257 WYQ 2024-12-03
90358 [DOTA]LTT-SS28 ,生长抑素模拟物 228 wyh 2024-12-03
90359 DOTA-minigastrin (CP04) , DOTA-小胃泌素(CP04) 282 wyh 2024-12-03
90360 DOTA-rhuEpo ; DOTA-酰肼偶联rhuEpo 153 wyh 2024-12-03
库存查询